Profile of circulating levels of IL-1Ra, CXCL10/IP-10, CCL4/MIP-1β and CCL2/MCP-1 in dengue fever and parvovirosis

de-Oliveira-Pinto, Luzia Maria; Gandini, Mariana; Freitas, Laís Picinini; Siqueira, Marilda Mendonça; Marinho, Cíntia Ferreira; Setúbal, Sérgio; Kubelka, Claire Fernandes; Cruz, Oswaldo Gonçalves; Oliveira, Solange Artimos de.
Mem. Inst. Oswaldo Cruz ; 107(1): 48-56, Feb. 2012. graf
Artigo em Inglês | LILACS | ID: lil-612805

Documentos relacionados

  1. Profile of circulating levels of IL-1Ra, CXCL10/IP-10, CCL4/MIP-1ß and CCL2/MCP-1 in dengue fever and parvovirosis.
  2. Severity of Plasma Leakage Is Associated With High Levels of Interferon γ-Inducible Protein 10, Hepatocyte Growth Factor, Matrix Metalloproteinase 2 (MMP-2), and MMP-9 During Dengue Virus Infection.
  3. IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines.
  4. Investigating the relationship between the VNTR variant of the interleukin-1 receptor antagonist gene and coronary in-stent restenosis.
  5. The role of icIL-1RA in keratinocyte senescence and development of the senescence-associated secretory phenotype.
  6. Association of genetic polymorphisms of IL1ß -511 C>T, IL1RN VNTR 86 bp, IL6 -174 G>C, IL10 -819 C>T and TNFα -308 G>A, involved in symptomatic patients with dengue in Brazil.
  7. [Role of interleukin-1 in human diseases: pharmacotherapy prospects: A review].
  8. Elevated IL-1ß and Comparable IL-1 Receptor Antagonist Levels Are Characteristic Features of L-PRP in Female College Athletes Compared to Male Professional Soccer Players.
  9. Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study.
  10. Patients diagnosed with COVID-19 and treated with anakinra: a real-world study in the USA.